Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORA·FANG vs Picosolution for Bowel Prep in Colorectal Cancer Surgery
NCT04593446Phase 2Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Orafang in colorectal cancer (CRC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Orafang
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04593446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04593446.